Cytokine gene therapy of gliomas: induction of reactive CD4+ T cells by interleukin-4-transfected 9L gliosarcoma is essential for protective immunity.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Cancer Research

• Publication date

  2000-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 10811123
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Exploitation of immune mechanisms in the treatment of central nervous system cancer.

  2000cited by this paper
• Effect of in situ retroviral interleukin-4 transfer on established intracranial tumors.

  1999cited by this paper
• Eradication of rat malignant gliomas by retroviral-mediated, in vivo delivery of the interleukin 4 gene.

  1999cited by this paper
• Injury to Autologous Normal Tissues and Tumors Mediated by Lymphokine-Activated Killer (LAK) Cells Generated In Vitro from Peripheral Blood Mononuclear Cells of Glioblastoma Patients

  1999cited by this paper
• Regression of intracerebral rat glioma isografts by therapeutic subcutaneous immunization with interferon-γ, interleukin-7, or B7-1-transfected tumor cells

  1999cited by this paper
• Anti‐tumor activity of interleukin‐2‐producing tumor cells and recombinant interleukin 12 against mouse glioma cells located in the central nervous system

  1999cited by this paper
• T Helper Cell Type 1–associated and Cytotoxic T Lymphocyte–mediated Tumor Immunity Is Impaired in Interleukin 4–deficient Mice

  1999cited by this paper
• Effective cytokine gene therapy against an intracranial glioma using a retrovirally transduced IL-4 plus HSVtk tumor vaccine

  1999cited by this paper
• Current therapy for brain tumors: back to the future.

  1999cited by this paper
• Complexities, pitfalls, and strategies for evaluating brain tumor therapies.

  1998cited by this paper
• IL-4 gene transfer for the treatment of experimental gliomas.

  1998cited by this paper
• Interleukin-12-based immunotherapy against rat 9L glioma.

  1998cited by this paper
• The concept of type-1 and type-2 helper T cells and their cytokines in humans.

  1998cited by this paper
• IL-4 in combination with TGF-beta favors an alternative pathway of Th1 development independent of IL-12.

  1998cited by this paper
• Systemic T cell adoptive immunotherapy of malignant gliomas.

  1998cited by this paper
• Treatment of intracranial gliomas in immunocompetent mice using herpes simplex viruses that express murine interleukins

  1998cited by this paper
• Inflammation in the CNS: balance between immunological privilege and immune responses.

  1998cited by this paper
• Demographics, prognosis, and therapy in 702 patients with brain metastases from malignant melanoma.

  1998cited by this paper
• Generation or large numbers of immature and mature dendritic cells from rat bone marrow cultures

  1998cited by this paper
• Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. II. Cytokine production and in vivo efficacy of glioma-sensitized lymphocytes

  1997cited by this paper
• Vaccination for experimental gliomas using GM-CSF-transduced glioma cells.

  1997cited by this paper
• Genetic modification of a carcinoma with the IL‐4 gene increases the influx of dendritic cells relative to other cytokines

  1997cited by this paper
• Intracerebral versus subcutaneous immunization with allogeneic fibroblasts genetically engineered to secrete interleukin-2 in the treatment of central nervous system glioma and melanoma.

  1997cited by this paper
• Adoptive immunotherapy of malignant glioma using tumor-sensitized T lymphocytes.

  1997cited by this paper
• Gene Therapy for Metastatic Brain Tumors by Vaccination with Granulocyte-Macrophage Colony-Stimulating Factor-Transduced Tumor Cells

  1997cited by this paper
• Induction of Antitumor Immunity by Intracerebrally Implanted Rat C6 Glioma Cells Genetically Engineered to Secrete Cytokines

  1997cited by this paper
• Granulocyte-macrophage colony-stimulating factor and B7-2 combination immunogene therapy in an allogeneic Hu-PBL-SCID/beige mouse-human glioblastoma multiforme model.

  1997cited by this paper
• Characterization of a spontaneous murine astrocytoma and abrogation of its tumorigenicity by cytokine secretion.

  1997cited by this paper
• Limited Efficacy of the HSV-TK/GCV System for Gene Therapy of Malignant Gliomas and Perspectives for the Combined Transduction of the Interleukin-4 Gene

  1997cited by this paper
• Treatment of murine gliomas by adoptive transfer of ex vivo activated tumor-draining lymph node cells.

  1997cited by this paper
• The paracrine role of tumour‐derived mIL‐4 on tumour‐associated endothelium

  1997cited by this paper
• Fas ligand expression by astrocytoma in vivo: maintaining immune privilege in the brain?

  1997cited by this paper
• Ex vivo expansion of tumor-draining lymph node cells using compounds which activate intracellular signal transduction. I. Characterization and in vivo anti-tumor activity of glioma-sensitized lymphocytes

  1997cited by this paper
• Treatment of intracranial tumors by systemic transfer of superantigen-activated tumor-draining lymph node T cells.

  1996cited by this paper
• Transforming growth factor‐β‐mediated autocrine growth regulation of gliomas as detected with phosphorothioate antisense oligonucleotides

  1996cited by this paper
• Intensified antitumor immunity by a cancer vaccine that produces granulocyte-macrophage colony-stimulating factor plus interleukin 4.

  1996cited by this paper
• Increased expression of Schwannoma‐derived growth factor (SDGF) mRNA in rat tumor cells: Involvement of SDGF in the growth promotion of rat gliomas

  1996cited by this paper
• Presence of MHC-I and B-7 molecules in rat and human glioma cells expressing antisense IGF-I mRNA.

  1996cited by this paper
• Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy.

  1996cited by this paper
• Systemic and local paracrine cytokine therapies using transduced tumor cells are synergistic in treating intracranial tumors.

  1996cited by this paper
• Fibroblasts genetically engineered to secrete cytokines suppress tumor growth and induce antitumor immunity to a murine glioma in vivo.

  1995cited by this paper
• Recombinant human interleukin 4 has antiproliferative activity on human tumor cell lines derived from epithelial and nonepithelial histologies.

  1995cited by this paper
• Local treatment of malignant gliomas by direct infusion of specific monoclonal antibodies labeled with 131I: comparison of the results obtained in recurrent and newly diagnosed tumors.

  1995cited by this paper
• Improved long term survival after intracavitary interleukin‐2 and lymphokine‐activated killer cells for adults with recurrent malignant glioma

  1995cited by this paper
• Human glioma-derived interleukin-10 inhibits antitumor immune responses in vitro.

  1995cited by this paper
• Cytokine-induced expression of vascular cell adhesion molecule-1 (VCAM-1) by astrocytes and astrocytoma cell lines.

  1995cited by this paper
• Prolonged survival of mice with glioma injected intracerebrally with double cytokine-secreting cells.

  1995cited by this paper
• An efficient Th2-type memory follows CD8+ lymphocyte-driven and eosinophil-mediated rejection of a spontaneous mouse mammary adenocarcinoma engineered to release IL-4.

  1994cited by this paper
• Efficacy of direct intratumoral therapy with targeted protein toxins for solid human gliomas in nude mice.

  1994cited by this paper
• Randomised, controlled study of intratumoral recombinant gamma-interferon treatment in newly diagnosed glioblastoma.

  1994cited by this paper
• Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-α and/or interferon-γ

  1993cited by this paper
• Modulation of proliferation and antigen expression of a cloned human glioblastoma by interleukin-4 alone and in combination with tumor necrosis factor-alpha and/or interferon-gamma.

  1993cited by this paper
• Treatment of glioma by engineered interleukin 4-secreting cells.

  1993cited by this paper
• The effect of transforming growth factor-beta 2-specific phosphorothioate-anti-sense oligodeoxynucleotides in reversing cellular immunosuppression in malignant glioma.

  1993cited by this paper
• Vaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.

  1993cited by this paper
• Transforming growth factor-beta 1, -beta 2, and -beta 3 secreted by a human glioblastoma cell line. Identification of small and different forms of large latent complexes.

  1992cited by this paper
• Antitumor activity against established intracerebral gliomas exhibited by cytotoxic T lymphocytes, but not by lymphokine-activated killer cells.

  1992cited by this paper
• Immunotherapy of human glioma xenografts with unlabeled, 131I-, or 125I-labeled monoclonal antibody 425 to epidermal growth factor receptor.

  1992cited by this paper
• Differential expression of transforming growth factor-beta 1, -beta 2, and -beta 3 by glioblastoma cells, astrocytes, and microglia.

  1992cited by this paper
• Cervical lymphatics, the blood-brain barrier and the immunoreactivity of the brain: a new view.

  1992cited by this paper
• Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial.

  1992cited by this paper
• Generation of cytotoxic immune responses against a rat glioma by in vivo priming and secondary in vitro stimulation with tumor cells.

  1992cited by this paper
• Malignant glioma modulation of immune function: relative contribution of different soluble factors.

  1991cited by this paper
• Modulation of T-cell function by gliomas.

  1991cited by this paper
• Treatment of established renal cancer by tumor cells engineered to secrete interleukin-4.

  1991cited by this paper
• Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.

  1990cited by this paper
• Adoptive immunotherapy of a rat glioma using lymphokine-activated killer cells and interleukin 2.

  1990cited by this paper
• Analysis of interleukin 2 and various effector cell populations in adoptive immunotherapy of 9L rat gliosarcoma: allogeneic cytotoxic T lymphocytes prevent tumor take.

  1990cited by this paper
• Inhibition of lymphocyte function by glioblastoma-derived transforming growth factor beta 2.

  1989cited by this paper
• Murine interleukin-4 displays potent anti-tumor activity in vivo.

  1989cited by this paper
• Systemic beta-interferon therapy for recurrent gliomas: a brief report.

  1989cited by this paper
• Systemic gamma-interferon therapy for recurrent gliomas.

  1988cited by this paper
• Concomitant production of different lymphokines in activated T cells

  1988cited by this paper
• Suppression of splenic natural killer cell activity in rats with brain tumors.

  1988cited by this paper
• Comparative localization of glioma-reactive monoclonal antibodies in vivo in an athymic mouse human glioma xenograft model.

  1987cited by this paper
• Potent and specific killing of human malignant brain tumor cells by an anti-transferrin receptor antibody-ricin immunotoxin.

  1987cited by this paper
• T cell suppressor factor from human glioblastoma cells is a 12.5‐kd protein closely related to transforming growth factor‐beta.

  1987cited by this paper
• Regulation of natural killer cell function by glass-adherent cells in patients with primary intracranial malignancies.

  1984cited by this paper
• Effect of human leukocyte interferon on malignant brain tumors

  1983cited by this paper
• Pediatric Neurology for the House Officer (2nd ed.)

  1983cited by this paper
• Prevention of glioma induction in rats by simultaneous intracerebral inoculation of avian sarcoma virus plus bacillus Calmette-Guerin cell-wall preparation.

  1983cited by this paper
• Production of prostaglandin E and an interleukin-1 like factor by cultured astrocytes and C6 glioma cells.

  1982cited by this paper
• Immunobiology of primary intracranial tumors. Part 4: levamisole as an immune stimulant in patients and in the ASV glioma model.

  1981cited by this paper
• Immunobiology of primary intracranial tumors.

  1977cited by this paper

• Vesicular Stomatitis Virus is a Malleable Oncolytic Vector for the Treatment of Various Malignancies

  2017cites this paper
• Immunomodulatory Effects of Hemagglutinin- (HA-) Modified A20 B-Cell Lymphoma Expanded as a Brain Tumor on Adoptively Transferred HA-Specific CD4+ T Cells

  2014cites this paper
• Ependymomas: development of immunotherapeutic strategies

  2013cites this paper
• Genomic Analysis of Stress Response against Arsenic in Caenorhabditis elegans

  2013cites this paper
• Peptide vaccine therapy for childhood gliomas.

  2013cites this paper
• and Promote Type-1 Immunity Activate Tumor-Infiltrating Dendritic Cells IL-4-Transfected Tumor Cell Vaccines

  2013cites this paper
• Brain Tumor Immunology and Immunotherapy

  2011cites this paper
• Genetic and Immunology of Brain Tumors

  2011cites this paper
• Immunotherapy of Brain Cancers: The Past, the Present, and Future Directions

  2011cites this paper
• Immunostimulants for malignant gliomas.

  2010cites this paper
• Stat3 Oncogenic Signaling in Glioblastoma Multiforme

  2009cites this paper
• Prevention of mammary carcinogenesis in MMTV-neu mice by cruciferous vegetable constituent benzyl isothiocyanate.

  2009cites this paper
• "Buy one get one free": armed viruses for the treatment of cancer cells and their microenvironment.

  2009cites this paper
• Brain Tumor Immunotherapy with Type‐1 Polarizing Strategies

  2009cites this paper
• The immunomodulatory role of angiocidin, a novel angiogenesis inhibitor.

  2009cites this paper
• Garlic constituent diallyl trisulfide prevents development of poorly differentiated prostate cancer and pulmonary metastasis multiplicity in TRAMP mice.

  2008cites this paper
• Expression of glioma-associated antigens in pediatric brain stem and non-brain stem gliomas

  2008cites this paper
• Gene therapy for the treatment of cancer: From laboratory to bedside

  2008cites this paper
• Cytokines and Cancer Vaccines

  2007cites this paper
• Glioma immunotherapy by IL‐21 gene‐modified cells or by recombinant IL‐21 involves antibody responses

  2007cites this paper
• Atopy and risk of brain tumors: a meta-analysis.

  2007cites this paper
• Cytokine Immuno-Gene Therapy for Malignant Brain Tumors

  2007cites this paper
• The TLR-7 Agonist, Imiquimod, Enhances Dendritic Cell Survival and Promotes Tumor Antigen-Specific T Cell Priming: Relation to Central Nervous System Antitumor Immunity1

  2006cites this paper
• Synergy of gene-mediated immunoprophylaxis and microbeam radiation therapy for advanced intracerebral rat 9L gliosarcomas

  2006cites this paper
• Antitumor Activity of T Cells Generated from Lymph Nodes Draining the SEA-expressing Murine B16 Melanoma and Secondarily Activated with Dendritic Cells

  2006cites this paper
• Immunotherapy for patients with malignant glioma: from theoretical principles to clinical applications

  2006cites this paper
• Immunogene therapy as a treatment for malignant brain tumors in young mice.

  2006cites this paper
• From laboratory to bedside

  2006cites this paper
• Delivery of Dendritic Cells Engineered to Secrete IFN-α into Central Nervous System Tumors Enhances the Efficacy of Peripheral Tumor Cell Vaccines: Dependence on Apoptotic Pathways1

  2005influential citation
• [Immunotherapy for brain tumor: don't get "Lost in Translation"].

  2005cites this paper
• Aberrant Stat 3 Signaling by Interleukin-4 in Malignant Glioma Cells : Involvement of IL-13 R a 2

  2005cites this paper
• Apoptotic Pathways Tumor Cell Vaccines: Dependence on Tumors Enhances the Efficacy of Peripheral into Central Nervous System a Secrete IFN-Delivery of Dendritic Cells Engineered to

  2005influential citation
• Tumor immunology, immunomics and targeted immunotherapy for central nervous system malignancies

  2005cites this paper
• Interleukin-4 gene transduced tumor cells promote a potent tumor-specific Th1-type response in cooperation with interferon-α transduction

  2005cites this paper
• Immunity Central Nervous System Antitumor Antigen-Specific T Cell Priming : Relation to Dendritic Cell Survival and Promotes Tumor The TLR-7 Agonist , Imiquimod , Enhances

  2005cites this paper
• IL-4-Transfected Tumor Cell Vaccines Activate Tumor-Infiltrating Dendritic Cells and Promote Type-1 Immunity1

  2005cites this paper
• Aberrant Stat3 signaling by interleukin-4 in malignant glioma cells: involvement of IL-13Ralpha2.

  2005cites this paper
• Cytokine gene therapy for malignant glioma

  2004cites this paper
• Delivery of Interferon-α Transfected Dendritic Cells into Central Nervous System Tumors Enhances the Antitumor Efficacy of Peripheral Peptide-Based Vaccines

  2004cites this paper
• Cellular immunity and immunotherapy of brain tumors.

  2004cites this paper
• Emerging molecular therapies for brain tumors.

  2004cites this paper
• mRNA expression of leukemia‐associated antigens in patients with acute myeloid leukemia for the development of specific immunotherapies

  2004cites this paper
• Biologic therapy for brain cancers--based on cellular and immunobiology.

  2004cites this paper
• CANCER GENE THERAPY USING CYTOKINE AND CHEMOKINE GENES

  2004cites this paper
• Oncolytic viral therapy and immunotherapy of malignant brain tumors: two potential new approaches of translational research

  2004cites this paper
• Expression of a Soluble Transforming Growth Factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcoma in vivo

  2004cites this paper
• Autologous Glioma Cell Vaccine Admixed with Interleukin-4 Gene Transfected Fibroblasts in the Treatment of Recurrent Glioblastoma: Preliminary Observations in a Patient with a Favorable Response to Therapy

  2004cites this paper
• Treatment with Allogeneic Interleukin-2 Secreting Fibroblasts Protects Against the Development of Malignant Brain Tumors

  2004cites this paper
• T-cell immune responses in the brain and their relevance for cerebral malignancies.

  2003cites this paper
• Autologous glioma cell vaccine admixed with interleukin-4 gene transfected fibroblasts in the treatment of recurrent glioblastoma: preliminary observations in a patient with a favorable response to therapy

  2003cites this paper
• Current and Future Gene Therapy for Malignant Gliomas

  2003cites this paper
• Cytokine Immuno-Gene Therapy for Treatment of Brain Tumors

  2003cites this paper
• Characterization of several leukemia‐associated antigens inducing humoral immune responses in acute and chronic myeloid leukemia

  2003cites this paper
• Generation of an effective anti‐tumor immunity after immunization with xenogeneic antigens

  2003cites this paper
• Human U251MG glioma cells expressing the membrane form of macrophage colony-stimulating factor (mM-CSF) are killed by human monocytes in vitro and are rejected within immunodeficient mice via paraptosis that is associated with increased expression of three different heat shock proteins

  2003cites this paper
• Treatment with allogeneic interleukin-2 secreting fibroblasts protects against the development of malignant brain tumors

  2003cites this paper
• Expression of a soluble transforming growth factor-β (TGFβ) receptor reduces tumorigenicity by regulating natural killer (NK) cell activity against 9L gliosarcomain vivo

  2003cites this paper
• Gene therapy of gliomas.

  2003cites this paper
• Immunotherapy and biological modifiers for the treatment of malignant brain tumors.

  2003cites this paper
• CD8+ T-cell mediated anti-tumor responses cross-reacting against 9L and RT2 rat glioma cell lines.

  2003cites this paper
• Local Therapies for Glioma Present Status and Future Developments

  2003cites this paper
• Approaches to the treatment of brain tumors using cytokine-secreting allogeneic fibroblasts

  2003cites this paper
• Nonviral Approaches for Cancer Gene Therapy

  2003cites this paper
• Dexamethasone inhibits the anti-tumor effect of interleukin 4 on rat experimental gliomas

  2003cites this paper
• CHAPTER 10 – Interleukin-4

  2003cites this paper
• Effective induction of antiglioma cytotoxic T cells by coadministration of interferon-β gene vector and dendritic cells

  2003cites this paper
• B7.1 immunogene therapy effectively activates CD(4+) tumor-infiltrating lymphocytes in the central nervous system in comparison with B7.2 gene therapy.

  2002cites this paper
• Immune responses in glioblastoma: an avenue to effective cancer therapy or a mere epiphenomenon?

  2002cites this paper
• Evaluation and optimization of DNA delivery into gliosarcoma 9L cells by a cholesterol-based cationic liposome.

  2002cites this paper
• 7-Hydroxystaurosporine-induced Apoptosis in 9L Glioma Cells Provides an Effective Antigen Source for Dendritic Cells and Yields a Potent Vaccine Strategy in an Intracranial Glioma Model

  2002cites this paper
• Genetically Engineered Vesicular Stomatitis Virus in Gene Therapy: Application for Treatment of Malignant Disease

  2002cites this paper
• Glioma-associated hyaluronan induces apoptosis in dendritic cells via inducible nitric oxide synthase: implications for the use of dendritic cells for therapy of gliomas.

  2002cites this paper
• Protective and Pathological Immune Responses in the CNS

  2002cites this paper
• Irradiated tumor cell vaccine for treatment of an established glioma. I. Successful treatment with combined radiotherapy and cellular vaccination

  2002cites this paper
• Retracted: Enhanced Inhibition of Tumour Growth and Metastasis, and Induction of Antitumour Immunity by IL‐2‐IgG2b Fusion Protein

  2002cites this paper
• The Combination of X-ray-mediated Radiosurgery and Gene-mediated Immunoprophylaxis for Advanced Intracerebral Gliosarcomas in Rats

  2002cites this paper
• Local tumor irradiation augments the antitumor effect of cytokine-producing autologous cancer cell vaccines in a murine glioma model

  2002cites this paper
• Cancer vaccines: dream, reality, or nightmare?

  2002cites this paper
• Clinical immunotherapy for brain tumors.

  2002cites this paper
• Induction of immunity in peripheral tissues combined with intracerebral transplantation of interleukin-2-producing cells eliminates established brain tumors.

  2001cites this paper
• Strategies using the immune system for therapy of brain tumors.

  2001cites this paper
• Immunization with an antigen identified by cytokine tumor vaccine-assisted SEREX (CAS) suppressed growth of the rat 9L glioma in vivo.

  2001cites this paper
• Combination of stereotactic radiosurgery and cytokine gene-transduced tumor cell vaccination: a new strategy against metastatic brain tumors.

  2001cites this paper
• Gene Therapy of Malignant Gliomas: A Pilot Study of Vaccination with Irradiated Autologous Glioma and Dendritic Cells Admixed with IL-4 Transduced Fibroblasts to Elicit an Immune Response

  2001cites this paper
• Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells

  2001cites this paper